Article | April 28, 2017

Accelerate Biopharmaceutical Development With Novel Analytical Techniques

Source: Catalent

By Michael Sadick, Ph.D. and Dan Papa, Catalent Biologics

Accelerate Biopharmaceutical Development With Novel Analytical Techniques

With the rising interest in biopharmaceuticals, drug developers need to quickly understand and evaluate the binding of therapeutic antibodies to Fc receptors. Learn how an Octet-based Fc receptor panel may help developers achieve a faster assessment of monoclonal antibody functionality—well before the final molecule is selected.